Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 53

1.

Survival skills ensure that cancer spreads.

Gomis RR.

Nature. 2019 Sep;573(7774):353-354. doi: 10.1038/d41586-019-02570-z. No abstract available.

PMID:
31530905
2.

From latency to overt bone metastasis in breast cancer: potential for treatment and prevention.

Salvador F, Llorente A, Gomis RR.

J Pathol. 2019 Sep;249(1):6-18. doi: 10.1002/path.5292. Epub 2019 Jun 27. Review.

3.

Correction: The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21.

Soria-Valles C, Gutiérrez-Fernández A, Guiu M, Mari B, Fueyo A, Gomis RR, López-Otín C.

Oncogene. 2019 Jul;38(28):5739. doi: 10.1038/s41388-019-0825-3.

PMID:
31053808
4.

Organ-specific metastases.

Urosevic J, Gomis RR.

Nat Biomed Eng. 2018 Jun;2(6):347-348. doi: 10.1038/s41551-018-0249-3. No abstract available.

PMID:
31011192
5.

Regulation of death receptor signaling by the autophagy protein TP53INP2.

Ivanova S, Polajnar M, Narbona-Perez AJ, Hernandez-Alvarez MI, Frager P, Slobodnyuk K, Plana N, Nebreda AR, Palacin M, Gomis RR, Behrends C, Zorzano A.

EMBO J. 2019 May 15;38(10). pii: e99300. doi: 10.15252/embj.201899300. Epub 2019 Apr 12.

PMID:
30979779
6.

CANCERTOOL: A Visualization and Representation Interface to Exploit Cancer Datasets.

Cortazar AR, Torrano V, Martín-Martín N, Caro-Maldonado A, Camacho L, Hermanova I, Guruceaga E, Lorenzo-Martín LF, Caloto R, Gomis RR, Apaolaza I, Quesada V, Trka J, Gomez-Muñoz A, Vincent S, Bustelo XR, Planes FJ, Aransay AM, Carracedo A.

Cancer Res. 2018 Nov 1;78(21):6320-6328. doi: 10.1158/0008-5472.CAN-18-1669. Epub 2018 Sep 19.

7.

Targeting p38α Increases DNA Damage, Chromosome Instability, and the Anti-tumoral Response to Taxanes in Breast Cancer Cells.

Cánovas B, Igea A, Sartori AA, Gomis RR, Paull TT, Isoda M, Pérez-Montoyo H, Serra V, González-Suárez E, Stracker TH, Nebreda AR.

Cancer Cell. 2018 Jun 11;33(6):1094-1110.e8. doi: 10.1016/j.ccell.2018.04.010. Epub 2018 May 24.

8.

CLK2 blockade modulates alternative splicing compromising MYC-driven breast tumors.

Salvador F, Gomis RR.

EMBO Mol Med. 2018 Jun;10(6). pii: e9213. doi: 10.15252/emmm.201809213. No abstract available.

9.

Clinical implications of the non-luminal intrinsic subtypes in hormone receptor-positive breast cancer.

Cejalvo JM, Pascual T, Fernández-Martínez A, Brasó-Maristany F, Gomis RR, Perou CM, Muñoz M, Prat A.

Cancer Treat Rev. 2018 Jun;67:63-70. doi: 10.1016/j.ctrv.2018.04.015. Epub 2018 May 7. Review.

10.

Publisher Correction: MSK1 regulates luminal cell differentiation and metastatic dormancy in ER+ breast cancer.

Gawrzak S, Rinaldi L, Gregorio S, Arenas EJ, Salvador F, Urosevic J, Figueras-Puig C, Rojo F, Del Barco Barrantes I, Cejalvo JM, Palafox M, Guiu M, Berenguer-Llergo A, Symeonidi A, Bellmunt A, Kalafatovic D, Arnal-Estapé A, Fernández E, Müllauer B, Groeneveld R, Slobodnyuk K, Stephan-Otto Attolini C, Saura C, Arribas J, Cortes J, Rovira A, Muñoz M, Lluch A, Serra V, Albanell J, Prat A, Nebreda AR, Benitah SA, Gomis RR.

Nat Cell Biol. 2018 Aug;20(8):990. doi: 10.1038/s41556-018-0052-0.

PMID:
29674681
11.

Paraspeckle factor turns TGF-β1 pro-metastatic.

Salvador F, Gomis RR.

Nat Cell Biol. 2018 Apr;20(4):367-369. doi: 10.1038/s41556-018-0078-3. No abstract available.

PMID:
29593320
12.

MSK1 regulates luminal cell differentiation and metastatic dormancy in ER+ breast cancer.

Gawrzak S, Rinaldi L, Gregorio S, Arenas EJ, Salvador F, Urosevic J, Figueras-Puig C, Rojo F, Del Barco Barrantes I, Cejalvo JM, Palafox M, Guiu M, Berenguer-Llergo A, Symeonidi A, Bellmunt A, Kalafatovic D, Arnal-Estapé A, Fernández E, Müllauer B, Groeneveld R, Slobodnyuk K, Stephan-Otto Attolini C, Saura C, Arribas J, Cortes J, Rovira A, Muñoz M, Lluch A, Serra V, Albanell J, Prat A, Nebreda AR, Benitah SA, Gomis RR.

Nat Cell Biol. 2018 Feb;20(2):211-221. doi: 10.1038/s41556-017-0021-z. Epub 2018 Jan 22. Erratum in: Nat Cell Biol. 2018 Apr 19;:.

PMID:
29358704
13.

Regulation of Mammary Luminal Cell Fate and Tumorigenesis by p38α.

Del Barco Barrantes I, Stephan-Otto Attolini C, Slobodnyuk K, Igea A, Gregorio S, Gawrzak S, Gomis RR, Nebreda AR.

Stem Cell Reports. 2018 Jan 9;10(1):257-271. doi: 10.1016/j.stemcr.2017.11.021. Epub 2017 Dec 28.

14.

Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial.

Coleman R, Hall A, Albanell J, Hanby A, Bell R, Cameron D, Dodwell D, Marshall H, Jean-Mairet J, Tercero JC, Rojo F, Gregory W, Gomis RR.

Lancet Oncol. 2017 Nov;18(11):1543-1552. doi: 10.1016/S1470-2045(17)30603-4. Epub 2017 Oct 13.

15.

Erratum: The metabolic co-regulator PGC1α suppresses prostate cancer metastasis.

Torrano V, Valcarcel-Jimenez L, Cortazar AR, Liu X, Urosevic J, Castillo-Martin M, Fernández-Ruiz S, Morciano G, Caro-Maldonado A, Guiu M, Zúñiga-García P, Graupera M, Bellmunt A, Pandya P, Lorente M, Martín-Martín N, Sutherland JD, Sanchez-Mosquera P, Bozal-Basterra L, Zabala-Letona A, Arruabarrena-Aristorena A, Berenguer A, Embade N, Ugalde-Olano A, Lacasa-Viscasillas I, Loizaga-Iriarte A, Unda-Urzaiz M, Schultz N, Aransay AM, Sanz-Moreno V, Barrio R, Velasco G, Pinton P, Cordon-Cardo C, Locasale JW, Gomis RR, Carracedo A.

Nat Cell Biol. 2017 Jun 29;19(7):873. doi: 10.1038/ncb3558.

PMID:
28659639
16.

Intrinsic Subtypes and Gene Expression Profiles in Primary and Metastatic Breast Cancer.

Cejalvo JM, Martínez de Dueñas E, Galván P, García-Recio S, Burgués Gasión O, Paré L, Antolín S, Martinello R, Blancas I, Adamo B, Guerrero-Zotano Á, Muñoz M, Nucíforo P, Vidal M, Pérez RM, Chacón López-Muniz JI, Caballero R, Peg V, Carrasco E, Rojo F, Perou CM, Cortés J, Adamo V, Albanell J, Gomis RR, Lluch A, Prat A.

Cancer Res. 2017 May 1;77(9):2213-2221. doi: 10.1158/0008-5472.CAN-16-2717. Epub 2017 Mar 1.

17.

TGF-β Family Signaling in Tumor Suppression and Cancer Progression.

Seoane J, Gomis RR.

Cold Spring Harb Perspect Biol. 2017 Dec 1;9(12). pii: a022277. doi: 10.1101/cshperspect.a022277. Review.

18.

EPCR promotes breast cancer progression by altering SPOCK1/testican 1-mediated 3D growth.

Perurena N, Zandueta C, Martínez-Canarias S, Moreno H, Vicent S, Almeida AS, Guruceaga E, Gomis RR, Santisteban M, Egeblad M, Hermida J, Lecanda F.

J Hematol Oncol. 2017 Jan 19;10(1):23. doi: 10.1186/s13045-017-0399-x.

19.

Understanding the molecular mechanisms driving metastasis.

Massagué J, Batlle E, Gomis RR.

Mol Oncol. 2017 Jan;11(1):3-4. doi: 10.1002/1878-0261.12024. No abstract available.

20.

Tumor cell dormancy.

Gomis RR, Gawrzak S.

Mol Oncol. 2017 Jan;11(1):62-78. doi: 10.1016/j.molonc.2016.09.009. Epub 2016 Oct 7. Review.

21.

Stem cell-like transcriptional reprogramming mediates metastatic resistance to mTOR inhibition.

Mateo F, Arenas EJ, Aguilar H, Serra-Musach J, de Garibay GR, Boni J, Maicas M, Du S, Iorio F, Herranz-Ors C, Islam A, Prado X, Llorente A, Petit A, Vidal A, Català I, Soler T, Venturas G, Rojo-Sebastian A, Serra H, Cuadras D, Blanco I, Lozano J, Canals F, Sieuwerts AM, de Weerd V, Look MP, Puertas S, García N, Perkins AS, Bonifaci N, Skowron M, Gómez-Baldó L, Hernández V, Martínez-Aranda A, Martínez-Iniesta M, Serrat X, Cerón J, Brunet J, Barretina MP, Gil M, Falo C, Fernández A, Morilla I, Pernas S, Plà MJ, Andreu X, Seguí MA, Ballester R, Castellà E, Nellist M, Morales S, Valls J, Velasco A, Matias-Guiu X, Figueras A, Sánchez-Mut JV, Sánchez-Céspedes M, Cordero A, Gómez-Miragaya J, Palomero L, Gómez A, Gajewski TF, Cohen EEW, Jesiotr M, Bodnar L, Quintela-Fandino M, López-Bigas N, Valdés-Mas R, Puente XS, Viñals F, Casanovas O, Graupera M, Hernández-Losa J, Ramón Y Cajal S, García-Alonso L, Saez-Rodriguez J, Esteller M, Sierra A, Martín-Martín N, Matheu A, Carracedo A, González-Suárez E, Nanjundan M, Cortés J, Lázaro C, Odero MD, Martens JWM, Moreno-Bueno G, Barcellos-Hoff MH, Villanueva A, Gomis RR, Pujana MA.

Oncogene. 2017 May 11;36(19):2737-2749. doi: 10.1038/onc.2016.427. Epub 2016 Dec 19.

22.

Stratification and therapeutic potential of PML in metastatic breast cancer.

Martín-Martín N, Piva M, Urosevic J, Aldaz P, Sutherland JD, Fernández-Ruiz S, Arreal L, Torrano V, Cortazar AR, Planet E, Guiu M, Radosevic-Robin N, Garcia S, Macías I, Salvador F, Domenici G, Rueda OM, Zabala-Letona A, Arruabarrena-Aristorena A, Zúñiga-García P, Caro-Maldonado A, Valcárcel-Jiménez L, Sánchez-Mosquera P, Varela-Rey M, Martínez-Chantar ML, Anguita J, Ibrahim YH, Scaltriti M, Lawrie CH, Aransay AM, Iovanna JL, Baselga J, Caldas C, Barrio R, Serra V, Vivanco Md, Matheu A, Gomis RR, Carracedo A.

Nat Commun. 2016 Aug 24;7:12595. doi: 10.1038/ncomms12595.

23.

The metabolic co-regulator PGC1α suppresses prostate cancer metastasis.

Torrano V, Valcarcel-Jimenez L, Cortazar AR, Liu X, Urosevic J, Castillo-Martin M, Fernández-Ruiz S, Morciano G, Caro-Maldonado A, Guiu M, Zúñiga-García P, Graupera M, Bellmunt A, Pandya P, Lorente M, Martín-Martín N, Sutherland JD, Sanchez-Mosquera P, Bozal-Basterra L, Zabala-Letona A, Arruabarrena-Aristorena A, Berenguer A, Embade N, Ugalde-Olano A, Lacasa-Viscasillas I, Loizaga-Iriarte A, Unda-Urzaiz M, Schultz N, Aransay AM, Sanz-Moreno V, Barrio R, Velasco G, Pinton P, Cordon-Cardo C, Locasale JW, Gomis RR, Carracedo A.

Nat Cell Biol. 2016 Jun;18(6):645-656. doi: 10.1038/ncb3357. Epub 2016 May 23. Erratum in: Nat Cell Biol. 2017 Jun 29;19(7):873.

24.

FoxA and LIPG endothelial lipase control the uptake of extracellular lipids for breast cancer growth.

Slebe F, Rojo F, Vinaixa M, García-Rocha M, Testoni G, Guiu M, Planet E, Samino S, Arenas EJ, Beltran A, Rovira A, Lluch A, Salvatella X, Yanes O, Albanell J, Guinovart JJ, Gomis RR.

Nat Commun. 2016 Apr 5;7:11199. doi: 10.1038/ncomms11199.

25.

Tumour stroma-derived lipocalin-2 promotes breast cancer metastasis.

Ören B, Urosevic J, Mertens C, Mora J, Guiu M, Gomis RR, Weigert A, Schmid T, Grein S, Brüne B, Jung M.

J Pathol. 2016 Jul;239(3):274-85. doi: 10.1002/path.4724. Epub 2016 Apr 29.

PMID:
27038000
26.

MiniAp-4: A Venom-Inspired Peptidomimetic for Brain Delivery.

Oller-Salvia B, Sánchez-Navarro M, Ciudad S, Guiu M, Arranz-Gibert P, Garcia C, Gomis RR, Cecchelli R, García J, Giralt E, Teixidó M.

Angew Chem Int Ed Engl. 2016 Jan 11;55(2):572-5. doi: 10.1002/anie.201508445. Epub 2015 Oct 23.

27.

Enhanced MAF Oncogene Expression and Breast Cancer Bone Metastasis.

Pavlovic M, Arnal-Estapé A, Rojo F, Bellmunt A, Tarragona M, Guiu M, Planet E, Garcia-Albéniz X, Morales M, Urosevic J, Gawrzak S, Rovira A, Prat A, Nonell L, Lluch A, Jean-Mairet J, Coleman R, Albanell J, Gomis RR.

J Natl Cancer Inst. 2015 Sep 15;107(12):djv256. doi: 10.1093/jnci/djv256. Print 2015 Dec.

28.

Mammary cancer stem cells reinitiation assessment at the metastatic niche: the lung and bone.

Guiu M, Arenas EJ, Gawrzak S, Pavlovic M, Gomis RR.

Methods Mol Biol. 2015;1293:221-9. doi: 10.1007/978-1-4939-2519-3_13.

PMID:
26040691
29.

MAPK signaling control of colon cancer metastasis.

Urosevic J, Nebreda AR, Gomis RR.

Cell Cycle. 2014;13(17):2641-2. doi: 10.4161/15384101.2014.946374. No abstract available.

30.

Colon cancer cells colonize the lung from established liver metastases through p38 MAPK signalling and PTHLH.

Urosevic J, Garcia-Albéniz X, Planet E, Real S, Céspedes MV, Guiu M, Fernandez E, Bellmunt A, Gawrzak S, Pavlovic M, Mangues R, Dolado I, Barriga FM, Nadal C, Kemeny N, Batlle E, Nebreda AR, Gomis RR.

Nat Cell Biol. 2014 Jul;16(7):685-94. doi: 10.1038/ncb2977. Epub 2014 Jun 1.

PMID:
24880666
31.

RARRES3 suppresses breast cancer lung metastasis by regulating adhesion and differentiation.

Morales M, Arenas EJ, Urosevic J, Guiu M, Fernández E, Planet E, Fenwick RB, Fernández-Ruiz S, Salvatella X, Reverter D, Carracedo A, Massagué J, Gomis RR.

EMBO Mol Med. 2014 Jul;6(7):865-81. doi: 10.15252/emmm.201303675.

32.

Cyclooxygenase-2 inhibitor suppresses tumour progression of prostate cancer bone metastases in nude mice.

Garcia M, Velez R, Romagosa C, Majem B, Pedrola N, Olivan M, Rigau M, Guiu M, Gomis RR, Morote J, Reventós J, Doll A.

BJU Int. 2014 May;113(5b):E164-77. doi: 10.1111/bju.12503. Epub 2014 Feb 14.

33.

The anti-metastatic activity of collagenase-2 in breast cancer cells is mediated by a signaling pathway involving decorin and miR-21.

Soria-Valles C, Gutiérrez-Fernández A, Guiu M, Mari B, Fueyo A, Gomis RR, López-Otín C.

Oncogene. 2014 Jun 5;33(23):3054-63. doi: 10.1038/onc.2013.267. Epub 2013 Jul 15. Erratum in: Oncogene. 2019 Jul;38(28):5739.

PMID:
23851508
34.

Constitutive HER2 signaling promotes breast cancer metastasis through cellular senescence.

Angelini PD, Zacarias Fluck MF, Pedersen K, Parra-Palau JL, Guiu M, Bernadó Morales C, Vicario R, Luque-García A, Navalpotro NP, Giralt J, Canals F, Gomis RR, Tabernero J, Baselga J, Villanueva J, Arribas J.

Cancer Res. 2013 Jan 1;73(1):450-8. doi: 10.1158/0008-5472.CAN-12-2301. Erratum in: Cancer Res. 2013 Oct 1;73(19):6095.

35.

Inhibition of specific NF-κB activity contributes to the tumor suppressor function of 14-3-3σ in breast cancer.

Inglés-Esteve J, Morales M, Dalmases A, Garcia-Carbonell R, Jené-Sanz A, López-Bigas N, Iglesias M, Ruiz-Herguido C, Rovira A, Rojo F, Albanell J, Gomis RR, Bigas A, Espinosa L.

PLoS One. 2012;7(5):e38347. doi: 10.1371/journal.pone.0038347. Epub 2012 May 31.

36.

Identification of NOG as a specific breast cancer bone metastasis-supporting gene.

Tarragona M, Pavlovic M, Arnal-Estapé A, Urosevic J, Morales M, Guiu M, Planet E, González-Suárez E, Gomis RR.

J Biol Chem. 2012 Jun 15;287(25):21346-55. doi: 10.1074/jbc.M112.355834. Epub 2012 Apr 30.

37.

Epithelial-mesenchymal transition can suppress major attributes of human epithelial tumor-initiating cells.

Celià-Terrassa T, Meca-Cortés O, Mateo F, Martínez de Paz A, Rubio N, Arnal-Estapé A, Ell BJ, Bermudo R, Díaz A, Guerra-Rebollo M, Lozano JJ, Estarás C, Ulloa C, Álvarez-Simón D, Milà J, Vilella R, Paciucci R, Martínez-Balbás M, de Herreros AG, Gomis RR, Kang Y, Blanco J, Fernández PL, Thomson TM.

J Clin Invest. 2012 May;122(5):1849-68. doi: 10.1172/JCI59218. Epub 2012 Apr 16.

38.

Tumor-stroma interactions a trademark for metastasis.

Morales M, Planet E, Arnal-Estape A, Pavlovic M, Tarragona M, Gomis RR.

Breast. 2011 Oct;20 Suppl 3:S50-5. doi: 10.1016/S0960-9776(11)70294-6.

39.

Accurate expression profiling of very small cell populations.

Gonzalez-Roca E, Garcia-Albéniz X, Rodriguez-Mulero S, Gomis RR, Kornacker K, Auer H.

PLoS One. 2010 Dec 28;5(12):e14418. doi: 10.1371/journal.pone.0014418.

40.

HER2 silences tumor suppression in breast cancer cells by switching expression of C/EBPß isoforms.

Arnal-Estapé A, Tarragona M, Morales M, Guiu M, Nadal C, Massagué J, Gomis RR.

Cancer Res. 2010 Dec 1;70(23):9927-36. doi: 10.1158/0008-5472.CAN-10-0869. Epub 2010 Nov 23.

41.

Genes that mediate breast cancer metastasis to the brain.

Bos PD, Zhang XH, Nadal C, Shu W, Gomis RR, Nguyen DX, Minn AJ, van de Vijver MJ, Gerald WL, Foekens JA, Massagué J.

Nature. 2009 Jun 18;459(7249):1005-9. doi: 10.1038/nature08021. Epub 2009 May 6.

42.

TGFbeta primes breast tumors for lung metastasis seeding through angiopoietin-like 4.

Padua D, Zhang XH, Wang Q, Nadal C, Gerald WL, Gomis RR, Massagué J.

Cell. 2008 Apr 4;133(1):66-77. doi: 10.1016/j.cell.2008.01.046.

43.

Mediators of vascular remodelling co-opted for sequential steps in lung metastasis.

Gupta GP, Nguyen DX, Chiang AC, Bos PD, Kim JY, Nadal C, Gomis RR, Manova-Todorova K, Massagué J.

Nature. 2007 Apr 12;446(7137):765-70.

PMID:
17429393
44.

C/EBPbeta at the core of the TGFbeta cytostatic response and its evasion in metastatic breast cancer cells.

Gomis RR, Alarcón C, Nadal C, Van Poznak C, Massagué J.

Cancer Cell. 2006 Sep;10(3):203-14.

45.

A FoxO-Smad synexpression group in human keratinocytes.

Gomis RR, Alarcón C, He W, Wang Q, Seoane J, Lash A, Massagué J.

Proc Natl Acad Sci U S A. 2006 Aug 22;103(34):12747-52. Epub 2006 Aug 14.

46.

The logic of TGFbeta signaling.

Massagué J, Gomis RR.

FEBS Lett. 2006 May 22;580(12):2811-20. Epub 2006 Apr 21. Review.

47.

Control of glycogen deposition.

Ferrer JC, Favre C, Gomis RR, Fernández-Novell JM, García-Rocha M, de la Iglesia N, Cid E, Guinovart JJ.

FEBS Lett. 2003 Jul 3;546(1):127-32. Review.

48.

Glucose 6-phosphate produced by gluconeogenesis and by glucokinase is equally effective in activating hepatic glycogen synthase.

Gomis RR, Favre C, García-Rocha M, Fernández-Novell JM, Ferrer JC, Guinovart JJ.

J Biol Chem. 2003 Mar 14;278(11):9740-6. Epub 2003 Jan 7.

49.

Expression of a green fluorescence protein-carrier protein into mouse spermatozoa.

Mogas T, Fernández-Novell JM, Palomo MJ, Otaegui PJ, Gomis RR, Ballester J, Izquierdo D, Guinovart JJ, Ferrer JC, Rigau T, Rodríguez-Gil JE.

Biochem Biophys Res Commun. 2002 Oct 4;297(4):841-6.

PMID:
12359229
50.

Liver glycogen synthase but not the muscle isoform differentiates between glucose 6-phosphate produced by glucokinase or hexokinase.

Gomis RR, Cid E, García-Rocha M, Ferrer JC, Guinovart JJ.

J Biol Chem. 2002 Jun 28;277(26):23246-52. Epub 2002 Mar 6.

Supplemental Content

Loading ...
Support Center